These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21175320)

  • 1. Neuromuscular blockers and ARDS.
    Puthucheary Z; Hart N; Montgomery H
    N Engl J Med; 2010 Dec; 363(26):2563. PubMed ID: 21175320
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular blockers and ARDS.
    Gusmão D
    N Engl J Med; 2010 Dec; 363(26):2562-3; author reply 2563-4. PubMed ID: 21175321
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular blockers and ARDS.
    Devlin JW; Garpestad E; Hill NS
    N Engl J Med; 2010 Dec; 363(26):2562; author reply 2563-4. PubMed ID: 21175322
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular blocking agents in ARDS.
    Slutsky AS
    N Engl J Med; 2010 Sep; 363(12):1176-80. PubMed ID: 20843254
    [No Abstract]   [Full Text] [Related]  

  • 5. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paralytics, Sedation, and Steroids in Acute Respiratory Distress Syndrome.
    Leap J; Hill J; Patel K; Shah A; Dumont T
    Crit Care Nurs Q; 2019; 42(4):376-391. PubMed ID: 31449148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year experience with an acute respiratory distress syndrome standard operating procedure on intensive care unit.
    Luedike P; Totzeck M; Rammos C; Kindgen-Milles D; Kelm M; Rassaf T
    J Crit Care; 2015 Oct; 30(5):1114-8. PubMed ID: 26216357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Paralysis for the Management of ARDS.
    Grawe ES; Bennett S; Hurford WE
    Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for muscle relaxation in patients with abdominal compartment syndrome?
    De Waele JJ; Benoit D; Hoste E; Colardyn F
    Intensive Care Med; 2003 Feb; 29(2):332. PubMed ID: 12675044
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.